Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
BMC Ophthalmology
Published in: BMC Ophthalmology 1/2023

Open Access 01-12-2023 | Research

Increased METTL3 expression and m6A RNA methylation may contribute to the development of dry eye in primary Sjögren’s syndrome

Authors: Jun Ma, Xiaotang Wang, Xue Yang, Xi Wang, Tongshan Tan, Hongping Fang, Yu Zhong, Qi Zhang

Published in: BMC Ophthalmology | Issue 1/2023

Login to get access

Abstract

Background

Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disorder defined by xerostomia and keratoconjunctivitis sicca, and its etiology remains unknown. N6-methyladenosine (m6A) is the predominant posttranscriptional modification in eukaryotic mRNAs and is dynamically regulated by m6A regulators. Dysregulation of m6A modification is closely associated with several autoimmune disorders, but the role of m6A modification in pSS remains unknown. This study investigated the potential role of m6A and m6A-related regulators in pSS patients with dry eye.

Methods

This cross-sectional study included forty-eight pSS patients with dry eye and forty healthy controls (HCs). Peripheral blood mononuclear cells (PBMCs) were isolated, and the level of m6A in total RNA was measured. The expression of m6A regulators was determined utilizing real-time PCR and western blotting. The serological indicators detected included autoantibodies, immunoglobulins (Igs), complement factors (Cs), and inflammatory indicators. Dry eye symptoms and signs were measured, including the ocular surface disease index, Schirmer’s test (ST), corneal fluorescein staining score (CFS), and tear break-up time. Spearman’s correlation coefficient was employed to assess the associations of m6A and m6A-related regulator expression with clinical characteristics.

Results

The expression level of m6A was markedly increased in the PBMCs of pSS patients with dry eye compared to HCs (P value<0.001). The relative mRNA and protein expression levels of the m6A regulators methyltransferase-like 3 (METTL3) and YT521-B homology domains 1 were markedly elevated in pSS patients with dry eye (both P value<0.01). The m6A RNA level was found to be positively related to METTL3 expression in pSS patients (r = 0.793, P value<0.001). Both the m6A RNA level and METTL3 mRNA expression correlated with the anti-SSB antibody, IgG, ST, and CFS (all P values < 0.05). The m6A RNA level was associated with C4 (r = -0.432, P value = 0.002), while METTL3 mRNA expression was associated with C3 (r = -0.313, P value = 0.030).

Conclusions

Our work revealed that the upregulation of m6A and METTL3 was associated with the performance of serological indicators and dry eye signs in pSS patients with dry eye. METTL3 may contribute to the pathogenesis of dry eye related to pSS.
Appendix
Available only for authorised users
Literature
1.
Brito-Zerón P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, Sivils K, Theander E, Tzioufas A, Ramos-Casals M. Sjögren syndrome. Nat Reviews Disease Primers 2016, 2(1).
2.
Konttinen YT, Porola P, Konttinen L, Laine M, Poduval P. Immunohistopathology of Sjogren’s syndrome. Autoimmun Rev. 2006;6(1):16–20.CrossRefPubMed
3.
Chivasso C, Sarrand J, Perret J, Delporte C, Soyfoo MS. The involvement of Innate and adaptive immunity in the initiation and perpetuation of Sjogren’s Syndrome. Int J Mol Sci 2021, 22(2).
4.
Nocturne G, Mariette X. B cells in the pathogenesis of primary Sjogren syndrome. Nat Rev Rheumatol. 2018;14(3):133–45.CrossRefPubMed
5.
Imgenberg-Kreuz J, Rasmussen A, Sivils K, Nordmark G. Genetics and epigenetics in primary Sjogren’s syndrome. Rheumatology (Oxford). 2021;60(5):2085–98.CrossRefPubMed
6.
Imgenberg-Kreuz J, Sandling JK, Nordmark G. Epigenetic alterations in primary Sjögren’s syndrome - an overview. Clin Immunol (Orlando Fla). 2018;196:12–20.CrossRef
7.
Pauley KM, Stewart CM, Gauna AE, Dupre LC, Kuklani R, Chan AL, Pauley BA, Reeves WH, Chan EKL, Cha S. Altered miR-146a expression in Sjögren’s syndrome and its functional role in innate immunity. Eur J Immunol. 2011;41(7):2029–39.CrossRefPubMedPubMedCentral
8.
Lv X, Zhou M, Zhang Q, He Y, Wang Y, Xuan J, Shi G, Li Y. Abnormal Histones Acetylation in patients with primary Sjogren’s Syndrome. Clin Rheumatol. 2022;41(5):1465–72.CrossRefPubMed
9.
Wang Y, Li L, Li J, Zhao B, Huang G, Li X, Xie Z, Zhou Z. The emerging role of m6A modification in regulating the Immune System and Autoimmune Diseases. Front Cell Dev Biol. 2021;9:755691.CrossRefPubMedPubMedCentral
10.
11.
Schwartz S, Mumbach MR, Jovanovic M, Wang T, Maciag K, Bushkin GG, Mertins P, Ter-Ovanesyan D, Habib N, Cacchiarelli D, et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5’ sites. Cell Rep. 2014;8(1):284–96.CrossRefPubMedPubMedCentral
12.
13.
Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K, Jacob-Hirsch J, Amariglio N, Kupiec M, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485(7397):201–6.CrossRefPubMed
14.
Meyer KD, Patil DP, Zhou J, Zinoviev A, Skabkin MA, Elemento O, Pestova TV, Qian SB, Jaffrey SR. 5’ UTR m(6)a promotes Cap-Independent translation. Cell. 2015;163(4):999–1010.CrossRefPubMedPubMedCentral
15.
Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20(10):608–24.CrossRefPubMed
16.
Wardowska A. m6A RNA methylation in systemic autoimmune Diseases-A New Target for epigenetic-based therapy? Pharmaceuticals (Basel) 2021, 14(3).
17.
Xiao J, Cai X, Wang R, Zhou W, Ye Z. Identification of Synovial Fibroblast-Associated Neuropeptide genes and m6A factors in rheumatoid arthritis using single-cell analysis and machine learning. Dis Markers. 2022;2022:5114697.CrossRefPubMedPubMedCentral
18.
Wang H, Hu X, Huang M, Liu J, Gu Y, Ma L, Zhou Q, Cao X. Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation. Nat Commun. 2019;10(1):1898.CrossRefPubMedPubMedCentral
19.
Huang H, Zhang G, Ruan G-X, Li Y, Chen W, Zou J, Zhang R, Wang J, Ji S-J, Xu S et al. Mettl14-Mediated m6A Modification Is Essential for Germinal Center B Cell Response. Journal of Immunology (Baltimore, Md: 1950) 2022, 208(8):1924–1936.
20.
Ito-Kureha T, Leoni C, Borland K, Cantini G, Bataclan M, Metzger RN, Ammann G, Krug AB, Marsico A, Kaiser S, et al. The function of Wtap in N6-adenosine methylation of mRNAs controls T cell receptor signaling and survival of T cells. Nat Immunol. 2022;23(8):1208–21.CrossRefPubMed
21.
Gu X, Zhang Y, Li D, Cai H, Cai L, Xu Q. N6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation. Cell Signal. 2020;69:109553.CrossRefPubMed
22.
Zhou J, Zhang X, Hu J, Qu R, Yu Z, Xu H, Chen H, Yan L, Ding C, Zou Q et al. m6A demethylase ALKBH5 controls CD4 + T cell pathogenicity and promotes autoimmunity. Sci Adv 2021, 7(25).
23.
Han D, Liu J, Chen C, Dong L, Liu Y, Chang R, Huang X, Liu Y, Wang J, Dougherty U, et al. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature. 2019;566(7743):270–4.CrossRefPubMedPubMedCentral
24.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, et al. Classification criteria for Sjögren’s syndrome: a revised version of the european criteria proposed by the american-european Consensus Group. Ann Rheum Dis. 2002;61(6):554–8.CrossRefPubMedPubMedCentral
25.
Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017;15(3):539–74.CrossRefPubMed
26.
Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640–50.CrossRefPubMed
27.
Imam H, Kim G-W, Siddiqui A. Epitranscriptomic(N6-methyladenosine) modification of viral RNA and virus-host interactions. Front Cell Infect Microbiol. 2020;10:584283.CrossRefPubMedPubMedCentral
28.
Paramasivam A, Priyadharsini JV, Raghunandhakumar S. Implications of m6A modification in autoimmune disorders. Cell Mol Immunol. 2020;17(5):550–1.CrossRefPubMed
29.
Wang J, Yan S, Lu H, Wang S, Xu D. METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-kappaB Signaling Pathway. Mediators Inflamm 2019, 2019:3120391.
30.
Song RH, Liu XR, Gao CQ, Du P, Zhang JA. METTL3 gene polymorphisms contribute to susceptibility to autoimmune thyroid disease. Endocrine 2020.
31.
Cheng L, Li H, Zhan H, Liu Y, Li X, Huang Y, Wang L, Zhang F, Li Y. Alterations of m6A RNA methylation regulators contribute to autophagy and immune infiltration in primary Sjogren’s syndrome. Front Immunol. 2022;13:949206.CrossRefPubMedPubMedCentral
32.
Brito-Zeron P, Kostov B, Solans R, Fraile G, Suarez-Cuervo C, Casanovas A, Rascon FJ, Qanneta R, Perez-Alvarez R, Ripoll M, et al. Systemic activity and mortality in primary Sjogren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann Rheum Dis. 2016;75(2):348–55.CrossRefPubMed
33.
Psianou K, Panagoulias I, Papanastasiou AD, de Lastic A-L, Rodi M, Spantidea PI, Degn SE, Georgiou P, Mouzaki A. Clinical and immunological parameters of Sjögren’s syndrome. Autoimmun rev. 2018;17(10):1053–64.CrossRefPubMed
34.
Zhu L, Li S, He S, Tong Q, Wang L, Li X, Wu X, Meng Q, Jin E, Zhang C, et al. The critical role of m(6)a methylation in the pathogenesis of Graves’ ophthalmopathy. Eye Vis (Lond). 2020;7(1):55.CrossRefPubMed
Metadata
Title
Increased METTL3 expression and m6A RNA methylation may contribute to the development of dry eye in primary Sjögren’s syndrome
Authors
Jun Ma
Xiaotang Wang
Xue Yang
Xi Wang
Tongshan Tan
Hongping Fang
Yu Zhong
Qi Zhang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2023
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-023-02988-0

Other articles of this Issue 1/2023

BMC Ophthalmology 1/2023 Go to the issue

Research

The influence of iris -ciliary angle (ICA) on the vault after implantation of V4c implantable collamer lens: a chain mediation model of ICL haptic related factors

Research

Analysis of choroidal thickness in juvenile systemic lupus erythematosus and its correlation with laboratory tests

Research

Clinical and in vivo confocal microscopy characteristics of Candida keratitis following keratoplasty

Case Report

Recanalization of Xen45 gel stent implant occlusion using 10 − 0 nylon suture in refractory glaucoma: a case report

Research

Evaluation of peripapillary retinal nerve fiber layer thickness in intracranial atherosclerotic stenosis

Research

Corneal thickness measurements with the RTVue, Casia-2, and Pentacam devices in patients with mild-to-moderate keratoconus: a comparative study